Sort
48,018 grants matching “immunotherapy”
Overcoming metastatic spread of osteosarcoma with RNA loaded nanoparticles
$531,320Elias Sayour · University Of Florida · R01 · FY2023 · CA
Core--Specimen
$531,317Nancy B. Kiviat · Fred Hutchinson Cancer Research Center · P50 · FY2008 · CA
Control of CD8+ T cell activation and differentiation by the signaling adaptor BCAP
$531,292Daniel J. Campbell · Benaroya Research Inst At Virginia Mason · R01 · FY2017 · AI
Control of CD8+ T cell activation and differentiation by the signaling adaptor BCAP
$531,292Daniel J. Campbell · Benaroya Research Inst At Virginia Mason · R01 · FY2016 · AI
Combination of ceramide and immunotherapy in treatment of hepatocellular cancer
$531,242Kevin Finnbar Staveleyo'carroll · University Of Missouri-Columbia · R01 · FY2017 · CA
Metabolic Regulation ofPD-L1 in CD11c+ Cells
$531,218Cong Yan · Indiana University Indianapolis · R01 · FY2020 · CA
Metabolic Regulation ofPD-L1 in CD11c+ Cells
$531,218Cong Yan · Indiana University Indianapolis · R01 · FY2021 · CA
Mechanisms of Murine Tumor Eradication by Immunotherapy
$531,207Philip D Greenberg · University Of Washington · R01 · FY2008 · CA
Project 2 - Modulation of Tumor-Induced Tolerance by Inhibitory Receptors
$531,128Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2025 · AI
Project 1 Targeting the PI3K Pathway to Overcome Resistance to Immunotherapy in Melanomas with Loss of PTEN
$531,105Michael Davies · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
The Tumor Microenvironment Niche of Type I conventional Dendritic Cells
$531,064Matthew F Krummel · University Of California, San Francisco · R01 · FY2023 · CA
The Tumor Microenvironment Niche of Type I conventional Dendritic Cells
$531,064Matthew F Krummel · University Of California, San Francisco · R01 · FY2025 · CA
The differentiation and function of CD4+ Th2 cells during allergen-induced asthma
$531,050Marion Pepper · University Of Washington · R01 · FY2015 · AI
Genetic Approaches to Optimize CAR T cells for Glioblastoma Therapy
$531,045Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2019 · NS
Defining the pathways activated by Toll-like Receptors to stimulate immunity
$531,000Jonathan C Kagan · Boston Children'S Hospital · R37 · FY2025 · AI
Defining the pathways activated by Toll-like Receptors to stimulate immunity
$531,000Jonathan C Kagan · Boston Children'S Hospital · R37 · FY2021 · AI
Defining the pathways activated by Toll-like Receptors to stimulate immunity
$531,000Jonathan C Kagan · Boston Children'S Hospital · R37 · FY2024 · AI
Defining the pathways activated by Toll-like Receptors to stimulate immunity
$531,000Jonathan C Kagan · Boston Children'S Hospital · R37 · FY2023 · AI
Defining the pathways activated by Toll-like Receptors to stimulate immunity
$531,000Jonathan C Kagan · Boston Children'S Hospital · R37 · FY2022 · AI
Molecular mechanism of RIG-I and RIPLET in antiviral signaling
$530,998Sun Hur · Boston Children'S Hospital · R01 · FY2022 · AI
Molecular mechanism of RIG-I and RIPLET in antiviral signaling
$530,998Sun Hur · Boston Children'S Hospital · R01 · FY2023 · AI
Molecular mechanism of RIG-I and RIPLET in antiviral signaling
$530,998Sun Hur · Boston Children'S Hospital · R01 · FY2019 · AI
Molecular mechanism of RIG-I and RIPLET in antiviral signaling
$530,998Sun Hur · Boston Children'S Hospital · R01 · FY2021 · AI
Molecular mechanism of RIG-I and RIPLET in antiviral signaling
$530,998Sun Hur · Boston Children'S Hospital · R01 · FY2020 · AI
Systems analysis of cell-cell communication networks and immune activity in the melanoma tumor microenvironment
$530,976Kathryn Miller-Jensen · Yale University · U01 · FY2024 · CA